Glaucoma News

Ocugen Aims for Three Gene Therapy Approvals to Democratize Treatment For decades, gene therapy has shimmered on the horizon of medicine—a revolutionary promise to cure, not just manage, inherited diseases. Yet, for many, it has remained a distant, often prohibitively expensive, beacon. One biotech company, Ocugen, is on a mission to change that narrative. With […]

PYC Therapeutics Advances Blinding Eye Disease Drug Trials: A New Dawn for Patients For the hundreds of thousands of individuals worldwide living with inherited retinal diseases (IRDs), the world can slowly fade to darkness. These genetic conditions, which include retinitis pigmentosa and Stargardt disease, have long been considered untreatable, leading to progressive vision loss and,

Protect Your Vision: 5 Daily Habits That Harm Your Eye Health We often think of our eyes as windows to the world, but do we treat them with the care they deserve? In our fast-paced, screen-dominated lives, it’s easy to take our vision for granted, assuming it will simply endure whatever we throw at it.

Lab-Grown Retina Reveals Genetic Cause of Rare Childhood Eye Disease For families navigating the difficult diagnosis of a rare childhood eye disease, the path forward is often shrouded in uncertainty. Many conditions lack clear genetic explanations, making prognosis and treatment planning a formidable challenge. Now, a groundbreaking study has illuminated one such shadowy corner of

A Young Hunter’s Dream: Bagging a Gobbler with a Rare Eye Disease The crisp morning air of Pennsylvania’s turkey woods holds a unique magic, a blend of anticipation, patience, and raw connection to nature. For most hunters, the challenge lies in outsmarting one of the wariest game birds in North America. But for 14-year-old Hunter

Lab-Grown Retina Uncovers Gene Clue for Rare Childhood Eye Disease For families navigating the complexities of a rare genetic condition, answers can feel frustratingly out of reach. This is especially true for Leber congenital amaurosis (LCA), a group of inherited retinal diseases that cause severe vision loss from infancy. But now, a groundbreaking approach using

How Free Eye Tests and Glasses Revived Paula’s Baking Passion For many of us, the simple joy of baking—the precision of measuring flour, the satisfaction of watching a cake rise, the love poured into icing a batch of cookies—is a cherished ritual. But for Paula, a dedicated Big Issue vendor in Edinburgh, that passion was

Immunovant’s Batoclimab Misses Key Goal: What Investors Should Do Now The high-stakes world of biotech investing is a rollercoaster of hope and data. For shareholders of Immunovant (NASDAQ: IMVT), the ride took a sharp downward turn recently with the announcement that its lead drug candidate, batoclimab, failed to meet its primary endpoint in a crucial

AI Chatbots Repeatedly Spread a Fake Eye Condition as Real In an era where we increasingly turn to AI for quick answers, a recent experiment has delivered a sobering reality check. Researchers from Canada and the UK decided to test a simple, yet profound, question: if you invent a fake medical condition and plant it

Senju Launches Innovative First-in-Class Dry Eye Drug in Japan For the millions in Japan suffering from the persistent discomfort of dry eye disease (DED), a new era of treatment has dawned. Senju Pharmaceutical Co., Ltd. has officially launched **TWYNA®**, a groundbreaking first-in-class drug offering a novel mechanism of action that moves beyond simple lubrication to